245 related articles for article (PubMed ID: 34819350)
1. TBX2 controls a proproliferative gene expression program in melanoma.
Lu S; Louphrasitthiphol P; Goradia N; Lambert JP; Schmidt J; Chauhan J; Rughani MG; Larue L; Wilmanns M; Goding CR
Genes Dev; 2021 Dec; 35(23-24):1657-1677. PubMed ID: 34819350
[TBL] [Abstract][Full Text] [Related]
2. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas.
Vance KW; Carreira S; Brosch G; Goding CR
Cancer Res; 2005 Mar; 65(6):2260-8. PubMed ID: 15781639
[TBL] [Abstract][Full Text] [Related]
3. The retinoblastoma protein modulates Tbx2 functional specificity.
Vance KW; Shaw HM; Rodriguez M; Ott S; Goding CR
Mol Biol Cell; 2010 Aug; 21(15):2770-9. PubMed ID: 20534814
[TBL] [Abstract][Full Text] [Related]
4. Combined genomic and proteomic approaches reveal DNA binding sites and interaction partners of TBX2 in the developing lung.
Lüdtke TH; Wojahn I; Kleppa MJ; Schierstaedt J; Christoffels VM; Künzler P; Kispert A
Respir Res; 2021 Mar; 22(1):85. PubMed ID: 33731112
[TBL] [Abstract][Full Text] [Related]
5. TBX2 expression is regulated by PAX3 in the melanocyte lineage.
Liu F; Cao J; Lv J; Dong L; Pier E; Xu GX; Wang RA; Xu Z; Goding C; Cui R
Pigment Cell Melanoma Res; 2013 Jan; 26(1):67-77. PubMed ID: 23020925
[TBL] [Abstract][Full Text] [Related]
6. UV-mediated regulation of the anti-senescence factor Tbx2.
Abrahams A; Mowla S; Parker MI; Goding CR; Prince S
J Biol Chem; 2008 Jan; 283(4):2223-30. PubMed ID: 18025091
[TBL] [Abstract][Full Text] [Related]
7. Physical and functional interaction between PML and TBX2 in the establishment of cellular senescence.
Martin N; Benhamed M; Nacerddine K; Demarque MD; van Lohuizen M; Dejean A; Bischof O
EMBO J; 2012 Jan; 31(1):95-109. PubMed ID: 22002537
[TBL] [Abstract][Full Text] [Related]
8. TBX3 and its splice variant TBX3 + exon 2a are functionally similar.
Hoogaars WM; Barnett P; Rodriguez M; Clout DE; Moorman AF; Goding CR; Christoffels VM
Pigment Cell Melanoma Res; 2008 Jun; 21(3):379-87. PubMed ID: 18444963
[TBL] [Abstract][Full Text] [Related]
9. The gene encoding the T-box factor Tbx2 is a target for the microphthalmia-associated transcription factor in melanocytes.
Carreira S; Liu B; Goding CR
J Biol Chem; 2000 Jul; 275(29):21920-7. PubMed ID: 10770922
[TBL] [Abstract][Full Text] [Related]
10. Ectopic Tbx2 expression results in polyploidy and cisplatin resistance.
Davis E; Teng H; Bilican B; Parker MI; Liu B; Carriera S; Goding CR; Prince S
Oncogene; 2008 Feb; 27(7):976-84. PubMed ID: 17700536
[TBL] [Abstract][Full Text] [Related]
11. Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.
Rodriguez M; Aladowicz E; Lanfrancone L; Goding CR
Cancer Res; 2008 Oct; 68(19):7872-81. PubMed ID: 18829543
[TBL] [Abstract][Full Text] [Related]
12. TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.
Crawford NT; McIntyre AJ; McCormick A; D'Costa ZC; Buckley NE; Mullan PB
Oncogene; 2019 Aug; 38(31):5971-5986. PubMed ID: 31253870
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle regulation of the T-box transcription factor tbx2.
Bilican B; Goding CR
Exp Cell Res; 2006 Jul; 312(12):2358-66. PubMed ID: 16730707
[TBL] [Abstract][Full Text] [Related]
14. Brachyury-related transcription factor Tbx2 and repression of the melanocyte-specific TRP-1 promoter.
Carreira S; Dexter TJ; Yavuzer U; Easty DJ; Goding CR
Mol Cell Biol; 1998 Sep; 18(9):5099-108. PubMed ID: 9710594
[TBL] [Abstract][Full Text] [Related]
15. The anti-proliferative function of the TGF-β1 signaling pathway involves the repression of the oncogenic TBX2 by its homologue TBX3.
Li J; Ballim D; Rodriguez M; Cui R; Goding CR; Teng H; Prince S
J Biol Chem; 2014 Dec; 289(51):35633-43. PubMed ID: 25371204
[TBL] [Abstract][Full Text] [Related]
16. T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells.
Redmond KL; Crawford NT; Farmer H; D'Costa ZC; O'Brien GJ; Buckley NE; Kennedy RD; Johnston PG; Harkin DP; Mullan PB
Oncogene; 2010 Jun; 29(22):3252-62. PubMed ID: 20348948
[TBL] [Abstract][Full Text] [Related]
17. TBX2 and TBX3: the special value for anticancer drug targets.
Lu J; Li XP; Dong Q; Kung HF; He ML
Biochim Biophys Acta; 2010 Dec; 1806(2):268-74. PubMed ID: 20624445
[TBL] [Abstract][Full Text] [Related]
18. The T box transcription factor TBX2 promotes epithelial-mesenchymal transition and invasion of normal and malignant breast epithelial cells.
Wang B; Lindley LE; Fernandez-Vega V; Rieger ME; Sims AH; Briegel KJ
PLoS One; 2012; 7(7):e41355. PubMed ID: 22844464
[TBL] [Abstract][Full Text] [Related]
19. Tbx2 mediates dorsal patterning and germ layer suppression through inhibition of BMP/GDF and Activin/Nodal signaling.
Reich S; Kayastha P; Teegala S; Weinstein DC
BMC Mol Cell Biol; 2020 May; 21(1):39. PubMed ID: 32466750
[TBL] [Abstract][Full Text] [Related]
20. T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis.
Cai CL; Zhou W; Yang L; Bu L; Qyang Y; Zhang X; Li X; Rosenfeld MG; Chen J; Evans S
Development; 2005 May; 132(10):2475-87. PubMed ID: 15843407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
